Tasigna International Website 
For Healthcare Professionals Outside the U.S.
U.S. Residents
Tasigna International Website 
For Healthcare Professionals Outside the U.S.
U.S. Residents
 
  • larger text larger text   
  • E-mail this page
  • print this page print this page
Back to Web Page  |  Print This Page
  
Search
Prescribing Information
Safety Information
English Deutsch Español Français Italiano
English
 Deutsch Español Français Italiano

About Tasigna®

European Summary of Product Characteristics

View the European Summary of Product Characteristics for Tasigna
View the European Summary of Product Characteristics for Tasigna

Information will display in PDF format.



 
Disclaimer: This is an international website for Tasigna® (nilotinib) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

Home | About Tasigna | Ph + CML Information | For Your Patients | News & Events | Resources | Product Information
About Novartis Oncology | Privacy Information | Site Map | Contact Us

Use of this website is subject to our Terms of Use.
© 2010 Novartis AG

Disclaimer: This is an international website for Tasigna® (nilotinib) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

Home | About Tasigna | Ph + CML Information | For Your Patients | News & Events | Resources | Product Information
About Novartis Oncology | Privacy Information | Site Map | Contact Us

Use of this website is subject to our Terms of Use.
© 2010 Novartis AG